Clopidogrel Improves Systemic Endothelial Nitric Oxide Bioavailability in Patients With Coronary Artery Disease: Evidence for Antioxidant and Antiinflammatory Effects

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  2006-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.ATV.0000225288.74170.dcPMID 16675725
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium.

  2005cited by this paper
• Effect of clopidogrel on the expression of inflammatory markers in rabbit ischemic coronary artery

  2005cited by this paper
• Urinary 8-iso-Prostaglandin F2&agr; as a Risk Marker in Patients With Coronary Heart Disease: A Matched Case-Control Study

  2004cited by this paper
• Quantification of Isoprostanes as Indices of Oxidant Stress and the Risk of Atherosclerosis in Humans

  2004cited by this paper
• Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerization.

  2004cited by this paper
• Reactive Oxygen Species: Players in the Platelet Game

  2004cited by this paper
• Effect of clopidogrel pretreatment on inflammatory marker expression in patients undergoing percutaneous coronary intervention.

  2004cited by this paper
• Clopidogrel inhibits platelet-leukocyte interactions and thrombin receptor agonist peptide-induced platelet activation in patients with an acute coronary syndrome.

  2004cited by this paper
• Glycoprotein IIb/IIIa inhibition enhances platelet nitric oxide release.

  2004cited by this paper
• Interleukin-10 serum levels and systemic endothelial vasoreactivity in patients with coronary artery disease.

  2004cited by this paper
• Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E

  2003cited by this paper
• Inhibitory Effects of Glycoprotein IIb/IIIa Antagonists and Aspirin on the Release of Soluble CD40 Ligand During Platelet Stimulation

  2003cited by this paper
• Platelet Glycoprotein IIb/IIIa Receptor Blockade Improves Vascular Nitric Oxide Bioavailability in Patients With Coronary Artery Disease

  2003cited by this paper
• A Critical Role of Platelet Adhesion in the Initiation of Atherosclerotic Lesion Formation

  2002cited by this paper
• Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization.

  2002cited by this paper
• CD40 Ligand Inhibits Endothelial Cell Migration by Increasing Production of Endothelial Reactive Oxygen Species

  2002cited by this paper
• Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study.

  2001cited by this paper
• Endothelial Dysfunction, Oxidative Stress, and Risk of Cardiovascular Events in Patients With Coronary Artery Disease

  2001cited by this paper
• For personal use. Only reproduce with permission from The Lancet Publishing Group. Late cardiopulmonary complication of ventriculo-atrial shunt

  2001cited by this paper
• Activated platelets mediate inflammatory signaling by regulated interleukin 1β synthesis

  2001cited by this paper
• RANTES Deposition by Platelets Triggers Monocyte Arrest on Inflamed and Atherosclerotic Endothelium

  2001influential reference
• Platelet CD40 ligand (CD40L) – subcellular localization, regulation of expression, and inhibition by clopidogrel

  2001cited by this paper
• Abciximab Suppresses the Rise in Levels of Circulating Inflammatory Markers After Percutaneous Coronary Revascularization

  2001cited by this paper
• Nitric oxide insufficiency, platelet activation, and arterial thrombosis.

  2001cited by this paper
• Elevated C-Reactive Protein Levels and Impaired Endothelial Vasoreactivity in Patients With Coronary Artery Disease

  2000cited by this paper
• Acute Systemic Inflammation Impairs Endothelium-Dependent Dilatation in Humans

  1999cited by this paper
• Novel inflammatory markers of coronary risk: theory versus practice.

  1999cited by this paper
• Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes.

  1999cited by this paper
• Reduction of atherosclerosis in mice by inhibition of CD40 signalling

  1998influential reference
• CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells

  1998cited by this paper

• Mitigation of thromboinflammation by rivaroxaban ameliorates metabolic and structural manifestations of metabolic dysfunction-associated steatohepatitis in rats: Comparison to other antithrombotic drugs.

  2025cites this paper
• Modulation of PI3K/AKT signaling and DFT modeling via selected pharmaceutical compounds attenuates carrageenan-induced inflammation and oxidative stress in rats

  2025cites this paper
• Platelet-Endothelial Cell–Cell Interactions at the Onset of Atherosclerosis: Mechanisms and Implications

  2025cites this paper
• Effect of drugs, medicinal herbal substances, fruits, coffee and tea on renal vessels in patients with and without renal failure

  2024cites this paper
• Superoxide Dismutase and Clopidogrel: A Potential Role in Peripheral Arterial Disease Treatment

  2024cites this paper
• The impact of platelets and antiplatelets medications on immune mediation

  2024cites this paper
• Antiplatelet therapy prior to COVID-19 infection impacts on patients mortality: a propensity score-matched cohort study

  2024cites this paper
• Familial catamenial coronary spasms

  2024cites this paper
• Cardiovascular benefits of air purifier in patients with stable coronary artery disease: A randomized single-blind crossover study

  2023cites this paper
• Antioxidant Properties of Oral Antithrombotic Therapies in Atherosclerotic Disease and Atrial Fibrillation

  2023cites this paper
• The role of platelet P2Y12 receptors in inflammation

  2023cites this paper
• Correlation between oxidative stress and clopidogrel drug in Iraqi patients with coronary artery disease

  2022cites this paper
• Where the Action Is—Leukocyte Recruitment in Atherosclerosis

  2022cites this paper
• Supplementation of Lipoic Acid, Zinc and Clopidogrel Reduces Mortality Rate and Incidence of Ventricular Arrhythmia in Experimental Myocardial Infarction

  2021cites this paper
• Clinical and Pharmacological Parameters Determine Relapse During Clopidogrel Treatment of Acute Coronary Syndrome

  2021cites this paper
• Effects of Monotherapy with Clopidogrel vs. Aspirin on Vascular Function and Hemostatic Measurements in Patients with Coronary Artery Disease: The Prospective, Crossover I-LOVE-MONO Trial

  2021cites this paper
• Pathological roles of platelets in inflammatory diseases: The emerging targets for new drug development

  2021cites this paper
• Clopidogrel Prophylaxis Abates Myocardial Ischemic Injury and Inhibits the Hyperlipidemia-Inflammation Loop in Hypercholestrolemic Mice.

  2020cites this paper
• Effect of Clopidogrel and Aspirin vs Aspirin Alone on Migraine Headaches After Transcatheter Atrial Septal Defect Closure: One-Year Results of the CANOA Randomized Clinical Trial.

  2020cites this paper
• The effect of antiplatelet drug on coronary endothelial and microvascular function: comparison with ticagrelor and clopidogrel

  2020cites this paper
• Endothelium as a Therapeutic Target in Diabetes Mellitus: From Basic Mechanisms to Clinical Practice.

  2020cites this paper
• Adenosine as a marker and mediator of cardiovascular homeostasis: a translational perspective.

  2019cites this paper
• The effect of inorganic nitrate and antiplatelet drugs on NO metabolites and platelet reactivity in patients with stable coronary artery disease

  2019cites this paper
• Monocyte-platelet aggregates affect local inflammation in patients with acute myocardial infarction.

  2019cites this paper
• Clopidogrel plus Aspirin Use is Associated with Worse Long-Term Outcomes, but Aspirin Use Alone is Safe in Patients with Vasospastic Angina: Results from the VA-Korea Registry, A Prospective Multi-Center Cohort

  2019cites this paper
• Targeting Early Atherosclerosis: A Focus on Oxidative Stress and Inflammation

  2019cites this paper
• Restoration of a stent-assisted thrombectomy-related middle cerebral artery stenosis: a case with 3 years’ follow-up

  2019cites this paper
• Comparison of Ticagrelor with Clopidogrel in Reducing Interleukin-17 and Myeloperoxidase Expression in Thrombus and Improving Postprocedural Coronary Flow in ST-segment Elevation Myocardial Infarction Patients.

  2018cites this paper
• Impact of different dosing regimens of clopidogrel on systemic oxidative stress in patients undergoing elective percutaneous coronary intervention

  2018cites this paper
• Potentiation of thrombus instability: a contributory mechanism to the effectiveness of antithrombotic medications

  2018cites this paper
• Combination Therapy with DETA/NO and Clopidogrel Inhibits Metastasis in Murine Mammary Gland Cancer Models via Improved Vasoprotection.

  2018cites this paper
• Peripheral revascularization attenuates the exercise pressor reflex and increases coronary exercise hyperemia in peripheral arterial disease.

  2018cites this paper
• Ticagrelor suppresses oxidized low-density lipoprotein-induced endothelial cell apoptosis and alleviates atherosclerosis in ApoE−/− mice via downregulation of PCSK9

  2018cites this paper
• Ticagrelor, a P2Y12 antagonist, attenuates vascular dysfunction and inhibits atherogenesis in apolipoprotein-E-deficient mice.

  2018cites this paper
• Interaction between platelets and endothelium: from pathophysiology to new therapeutic options.

  2018cites this paper
• A literature review of antithrombotic and anticoagulating agents on sexual function

  2017cites this paper
• Clopidogrel in a combined therapy with anticancer drugs—effect on tumor growth, metastasis, and treatment toxicity: Studies in animal models

  2017cites this paper
• Ticagrelor: Effects Beyond the P2Y12 Receptor.

  2017cites this paper
• Effects of clopidogrel on inflammatory cytokines and adhesion molecules in human endothelial cells: Role of nitric oxide mediating pleiotropic effects

  2017cites this paper
• Atorvastatin combined with ticagrelor prevent ischemia-reperfusion induced vascular endothelial dysfunction in healthy young males - A randomized, placebo-controlled, double-blinded study.

  2017cites this paper
• Therapeutic Targeting of Cellular Stress to Prevent Cardiovascular Disease: A Review of the Evidence

  2017cites this paper
• Prasugrel as opposed to clopidogrel improves endothelial nitric oxide bioavailability and reduces platelet-leukocyte interaction in patients with unstable angina pectoris: A randomized controlled trial.

  2017cites this paper
• The Effect of Clopidogrel on the Response to Ischemia Reperfusion

  2017cites this paper
• The effect of inorganic nitrate and nitrite on the production and function of extracellular vesicles

  2017cites this paper
• Ticagrelor mitigates ischaemia–reperfusion induced vascular endothelial dysfunction in healthy young males – a randomized, single‐blinded study

  2017cites this paper
• Platelet CD40L induces activation of astrocytes and microglia in hypertension.

  2017cites this paper
• Platelet-derived chemokines in inflammation and atherosclerosis.

  2017cites this paper
• The influence of clopidogrel on ischemia diagnosed by myocardial perfusion stress testing

  2016cites this paper
• Impact of C34T P2Y12 ADP receptor polymorphism and smoking status on cardiovascular outcome in coronary artery disease patients receiving clopidogrel.

  2016cites this paper
• The Impact of Antiplatelet Treatment on Endothelial Function.

  2016cites this paper
• The Metabolism of Clopidogrel: CYP2C19 Is a Minor Pathway

  2016cites this paper
• Impact of CYP2C19 Variants on Clinical Efficacy of Clopidogrel and 1-Year Clinical Outcomes in Coronary Heart Patients Undergoing Percutaneous Coronary Intervention

  2016cites this paper
• The effect of thienopyridines and non-thienopyridines on nitric oxide metabolism in patients with stable angina

  2016cites this paper
• Targeting Select Cellular Stress Pathways to Prevent Hyperglycemia-Related Complications: Shifting the Paradigm

  2016cites this paper
• Clopidogrel Improves Skin Microcirculatory Endothelial Function in Persons With Heightened Platelet Aggregation

  2016cites this paper
• Treatment with Clopidogrel Prior to Acute Non-Cardioembolic Ischemic Stroke Attenuates Stroke Severity

  2016cites this paper
• Effects of P2Y12 receptor antagonists beyond platelet inhibition – comparison of ticagrelor with thienopyridines

  2016cites this paper
• Similar Impact of Clopidogrel or Ticagrelor on Carotid Atherosclerotic Plaque Inflammation

  2016cites this paper
• Mechanism of action of antiplatelet drugs on decompression sickness in rats: a protective effect of anti-GPIIbIIIa therapy.

  2015cites this paper
• Rates and predictors of 5-year survival in a national cohort of asymptomatic elderly patients undergoing carotid revascularization.

  2015cites this paper
• Aspirin and P2Y12 Inhibitors in platelet-mediated activation of neutrophils and monocytes

  2015cites this paper
• Soluble CD40 Ligand in Aspirin-Treated Patients Undergoing Cardiac Catheterization

  2015cites this paper
• Effects of CYP2C19 Polymorphism on Endothelial Function, Arterial Stiffness and Inflammation in Coronary Artery Disease Patients Under Clopidogrel Treatment.

  2015cites this paper
• Effects of memantine and clopidogrel alone and in combination in a cerebral ischemia-reperfusion model

  2015cites this paper
• Effect of Clopidogrel and Aspirin vs Aspirin Alone on Migraine Headaches After Transcatheter Atrial Septal Defect Closure: The CANOA Randomized Clinical Trial.

  2015cites this paper
• The role of platelets in the recruitment of leukocytes during vascular disease

  2015cites this paper
• The Effect of Antiplatelet Medications on Innate Immune Activation

  2015influential citation
• Genetic determined low response to thienopyridines is associated with higher systemic inflammation in smokers.

  2015cites this paper
• Protective effects of ginseng extracts and common anti-aggregant drugs on ischaemia–reperfusion injury

  2015cites this paper
• Efficacy and safety of cangrelor for patients with coronary artery disease: a meta-analysis of four randomized trials.

  2015cites this paper
• Effect of P2Y12 inhibitors on inflammation and immunity

  2015influential citation
• Non‐antiplatelet effect of clopidogrel: improving endothelial function in Chinese healthy subjects with different CYP2C19 genotype

  2015cites this paper
• Clopidogrel response variability is associated with endothelial dysfunction in coronary artery disease patients receiving dual antiplatelet therapy.

  2015cites this paper
• Microvascular integrity plays an important role for graft survival after experimental skin transplantation.

  2015cites this paper
• Platelets, inflammation and anti-inflammatory effects of antiplatelet drugs in ACS and CAD

  2015cites this paper
• Soluble CD 40 Ligand in Aspirin-Treated Patients Undergoing Cardiac Catheterization

  2015cites this paper
• Clopidogrel: A multifaceted affair

  2015cites this paper
• Clinical Study Association between Peak Neutrophil Count , Clopidogrel Loading Dose , and Left Ventricular Systolic Function in Patients with Primary Percutaneous Coronary Intervention

  2015cites this paper
• HIGH PLATELET REACTIVITY IS ASSOCIATED WITH VASCULAR FUNCTION IN PATIENTS AFTER PERCUTANEOUS CORONARY INTERVENTION RECEIVING CLOPIDOGREL

  2015cites this paper
• Investigation of possible prophylactic, renoprotective, and cardioprotective effects of thromboprophylactic drugs against ischemia–reperfusion injury

  2015cites this paper
• Evaluating digital vascular perfusion and platelet dysfunction in Raynaud's phenomenon and systemic sclerosis

  2014cites this paper
• THIENOPYRIDINES, BEYOND ADP ANTAGONISM: A REVIEW OF PLEIOTROPIC EFFECTS

  2014cites this paper
• Factors determining the total serum antioxidant capacity in men with coronary heart disease--the powerful effect of treatment with thienopyridines.

  2014cites this paper
• A new mechanism of action of thienopyridine antiplatelet drugs - a role for gastric nitrosthiol metabolism?

  2014cites this paper
• A retrospective review of clopidogrel as primary therapy for migraineurs with right to left shunt lesions

  2014cites this paper
• Association between Peak Neutrophil Count, Clopidogrel Loading Dose, and Left Ventricular Systolic Function in Patients with Primary Percutaneous Coronary Intervention

  2014cites this paper
• Clopidogrel improves microvascular endothelial function in subjects with stable coronary artery disease.

  2014influential citation
• Effects of CYP2C19 and P2Y12 Gene Polymorphisms on Clinical Results of Patients Using Clopidogrel after Acute Ischemic Cerebrovascular Disease

  2014cites this paper
• Impact of C34T P2Y12 genotype on endothelial function and arterial stiffness in patients after percutaneous coronary intervention receiving clopidogrel.

  2014cites this paper
• High platelet reactivity is associated with vascular function in patients after percutaneous coronary intervention receiving clopidogrel.

  2014cites this paper
• Pleiotropic effects of platelet P2Y12 receptor inhibitors: fact or fiction?

  2014cites this paper
• Effects of Clopidogrel Therapy on Oxidative Stress, Inflammation, Vascular Function, and Progenitor Cells in Stable Coronary Artery Disease

  2014cites this paper
• Prasugrel erhöht die endotheliale Bioverfügbarkeit von NO im Vergleich zu Clopidogrel bei Patienten mit instabiler Angina Pectoris

  2014cites this paper
• The impact of CYP2C19 genotype on cardiovascular events and platelet reactivity in patients with coronary artery disease receiving clopidogrel.

  2013cites this paper
• Does drug therapy reverse endothelial progenitor cell dysfunction in diabetes?

  2013cites this paper
• Cytochrome P450 and inflammation : pharmacogenomic approach and molecular aspects of anti-inflammatory effects of theinopyridines

  2013cites this paper
• Clinical Implications of Platelet—Vessel Interaction

  2013cites this paper
• Antiatherosclerotic Potential of Clopidogrel: Antioxidant and Anti-Inflammatory Approaches

  2013cites this paper
• High-Maintenance-Dose Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis

  2013cites this paper
• Newly identified synergy between clopidogrel and calcium-channel blockers for blood pressure regulation possibly involves CYP2C19 rs4244285.

  2013cites this paper